MoneyWorks4Me

Windlas Biotech - Quaterly Results

12 May 2022 Evaluate
The company witnessed a 14.35% growth in the revenue at Rs. 1221.31 millions for the quarter ended March 2022 as compared to Rs. 1068.09 millions during the year-ago period.The company almost doubled its revenue to Rs. 152.33 millions  from Rs. 58.91 millions in the quarter ended March 2022.OP of the company witnessed a marginal growth to 172.90 millions from 119.02 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1221.31 1068.09 14.35 4659.30 4276.02 8.96 4659.30 4276.02 8.96
Other Income 30.05 7.93 278.94 67.06 30.94 116.74 67.06 30.94 116.74
PBIDT 172.90 119.02 45.27 596.01 577.86 3.14 596.01 577.86 3.14
Interest 2.88 3.24 -11.11 14.17 12.90 9.84 14.17 12.90 9.84
PBDT 170.02 115.78 46.85 581.84 241.45 140.98 581.84 241.45 140.98
Depreciation 29.02 33.58 -13.58 121.47 129.65 -6.31 121.47 129.65 -6.31
PBT 141.00 82.20 71.53 460.37 111.80 311.78 460.37 111.80 311.78
TAX -11.33 23.29 -148.65 74.76 61.70 21.17 74.76 61.70 21.17
Deferred Tax -28.50 -1.80 1483.33 -26.57 13.28 -300.08 -26.57 13.28 -300.08
PAT 152.33 58.91 158.58 385.61 50.10 669.68 385.61 50.10 669.68
Equity 108.97 64.11 69.97 108.97 64.11 69.97 108.97 64.11 69.97
PBIDTM(%) 14.16 11.14 27.04 12.79 13.51 -5.34 12.79 13.51 -5.34
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..